DIPSO CAS 68399-80-4 - Manufacturers, Factory, Suppliers from China

DIPSO CAS 68399-80-4, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

DIPSO Sodium Salt CAS 102783-62-0 Purity >98.0% (Titration) Biological Buffer Extrapure

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Top Selling Products

Related Blog
Reviews

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...

2022.12.04 03:59:02
2022.04.19 16:13:07
2022.03.27 16:11:58
2022.02.21 00:07:11
2022.02.14 17:35:26
2021.10.13 13:52:06

DIPSO CAS 68399-80-4 - Manufacturers, Factory, Suppliers from China

Related Products

DIPSO CAS 68399-80-4 Purity >99.0% (Titration) Biological Buffer Ultra Pure Factory

DIPSO Sodium Salt CAS 102783-62-0 Purity >98.0% (Titration) Biological Buffer Extrapure

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Top Selling Products

Z-Phe-OSu CAS 3397-32-8 Purity >98.0% (HPLC)

2-Bromo-3-Fluoropyridine CAS 40273-45-8 Purity >98.0% (GC) Factory

Tris(trimethylsilyl) Borate (TMSB) CAS 4325-85-3 Purity >99.0% (GC) Electrolyte Additive

Methyl Nicotinate CAS 93-60-7 Purity >99.0% (GC)

Felodipine CAS 72509-76-3 ; 86189-69-7 Assay 98.0~101.0% (HPLC)

Fmoc-Cit-OH CAS 133174-15-9 Fmoc-L-Citrulline Purity >99.0% (HPLC) Factory

2-Hydroxypyrazine CAS 6270-63-9 Purity >97.0% (HPLC)

4,6-Dimethoxy-2-(methylsulfonyl)pyrimidine CAS 113583-35-0 Purity >99.0% (GC) Factory High Quality

4,5-Dimethoxy-1-Cyanobenzocyclobutane CAS 35202-54-1 Purity >99.0% (HPLC) Ivabradine Hydrochloride Intermediate Factory

L-Propargylglycine CAS 198774-27-5 Purity >98.0% (HPLC) Factory

3-Bromo-2-Nitropyridine CAS 54231-33-3 Purity >98.0% (HPLC) Factory

2,4-Dichloro-5-Sulfamoylbenzoic Acid CAS 2736-23-4 Furosemide Intermediate Factory

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

Paxlovid: what we know about Pfizer's Covid-19 pill

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

The “Summit on COVID-19 Diagnostics & Treatment”

2022.12.04 03:59:02

2022.04.19 16:13:07

2022.03.27 16:11:58

2022.02.21 00:07:11

2022.02.14 17:35:26

2021.10.13 13:52:06

related search